中国高校科技期刊研究会第9次会员代表大会在北京召开，中宣部出版局副局长张怀海、教育部科学技术与信息化司一级巡视员张国辉等领导出席会议并发表..
英文简介：Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world.中文简介：（来自Google、百度翻译）皮肤病学和治疗是国际，开放获取，同行评审，快速发表的期刊 (同行评审在2周内，在接受后3-4周内发表)。该杂志致力于围绕皮肤疗法的发现，开发和使用发表高质量的临床 (所有阶段)，观察性，现实世界和健康结果研究。还鼓励与诊断，药物经济学，公共卫生和流行病学，生活质量以及患者护理，管理和教育有关的研究。 重点领域包括但不限于皮肤病学的所有临床方面，例如皮肤药理学; 皮肤发育和衰老; 皮肤疾病和黑色素瘤的预防，诊断和管理; 皮肤结构和病理学研究; 以及美容皮肤病学的所有领域，包括皮肤维护，皮肤病学手术，和激光。 该杂志引起了广泛的制药和医疗保健专业人士的兴趣，并发表了原创研究，评论，病例报告/病例系列，试验方案和简短的交流。皮肤病学和治疗将考虑所有科学上合理的研究，无论是阳性，验证性还是阴性数据。无论是与国际和/或特定国家/地区的受众有关，都欢迎提交，当研究人员试图针对更特定的患者人群时，这一点至关重要。这种包容性的方法使期刊能够协助传播高质量的研究，而其他期刊可能认为这没有足够的兴趣。该杂志吸引了全球读者，并收到了来自世界各地的意见书。
